The CHD4 point mutations were found in several types of BC (lobular and ductal carcinoma, invasive, metastatic, neuroendocrine, phyllodes), with different BC clinical classification [see Supplementary Table 1 and Figure 1, (41–54)]. This evidence concerns the gene CHD4 and breast cancer.